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Purpose: A combined diffusion-relaxometryMR acquisition
and analysis pipeline for in-vivo human placenta, which al-
lows for exploration of coupling between T2* and appar-
ent diffusion coefficient (ADC) measurements in a sub 10
minute scan time.
Methods: We present a novel acquisition combining a diffu-
sion prepared spin-echowith subsequent gradient echoes.
The placentas of 17 pregnant womenwere scanned in-vivo,
including both healthy controls and participants with var-
ious pregnancy complications. We estimate the joint T2*-
ADC spectra using an inverse Laplace transform.
Results: T2*-ADC spectra demonstrate clear quantitative
separation between normal and dysfunctional placentas.
Conclusions: Combined T2*-diffusivityMRI is promising for
assessing fetal andmaternal health during pregnancy. The
T2*-ADC spectrum potentially provides additional informa-
tion on tissuemicrostructure, compared tomeasuring these
two contrasts separately. The presentedmethod is immedi-
ately applicable to the study of other organs.
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1 | INTRODUCTION
Theplacenta provides the vital link betweenmother and fetus duringpregnancy. It is implicated inmanymajor pregnancy
complications, such as pre-eclampsia (PE) and fetal growth restriction (FGR) [1]. PE affects 3-5% of pregnancies [2] and
is a major cause of maternal and perinatal mortality [3, 4]. Late onset FGR, defined as that diagnosed after 32weeks [5],
affects 5-10% of pregnancies [6]. It is strongly associated with stillbirth [7, 8], pre-eclampsia [9], and late preterm birth
[10]. For all these disorders, it is likely that placental dysfunction occurs before the onset of symptoms. New techniques
for imaging the placenta therefore have the potential to improve prediction, diagnosis, andmonitoring of pregnancy
complications.
Placental MRI is emerging as a technique with substantial promise to overcome some disadvantages of ultrasound.
For example, ultrasound parameters of fetal wellbeing are imperfect for determining which fetuses have late-onset FGR
and are at greatest risk of adverse perinatal outcome, as opposed to those that are constitutionally small but healthy
[11, 6]. Assessing the placenta withMRI has the potential to make this distinction. TwoMRImodalities that show great
promise for assessing placental function are T2∗ relaxometry - which has the potential to estimate oxygenation levels
[12, 13], and diffusionMRI (dMRI) - which can estimatemicrostructure andmicrocirculatory properties [14, 15, 16, 17].
T2∗ relaxometry exploits the inherent sensitivity of the transverse relaxation time to the biochemical environment
of tissue. In particular, the paramagnetic properties of haemoglobinmean that the T2* time constant can be used as a
proxy estimation of oxygenation [18]. In placental studies, T2* is generally lower in FGR cases [19, 20, 21, 22]. A typical
experiment acquires gradient echo data at several echo times (TE), either in separate ormulti-echo scans, and hence
estimates the T2* constant of the tissue. No diffusion weighting is typically applied to these scans. Applying diffusion
gradients with different strengths (b-value) and directions provides sensitivity to various microstructural length scales
and orientations. Thesemeasurements are usually taken at a fixed TE. In the placenta, dMRI has shown promise for
discrimination between normal pregnancies and FGR [23, 24, 14, 25, 15, 26], and early onset PE [16]. However, despite
the large number of placental T2* and dMRI studies in the literature, nomethod has shown sufficient discrimination
between healthy pregnancies and those with complications to be introduced into routine clinical practice. Methods
which combinemultiple distinct measurements may provide a way to overcome this. Supporting Information Table S1
summarises T2* and dMRI studies in the placenta to date.
T2* and dMRI-derivedmeasures are both influenced by the presence and composition of distinct tissue compart-
ments (ormicroenvironments). Diffusion-relaxometry MRI can simultaneously measure multiple MR contrasts; for
example by varying both TE and b-value it is possible to probe themultidimensional T2-diffusivity (or T2*-diffusivity)
space. MR experiments dating back to the 1990s have simultaneously measured diffusivity and T2 [27, 28, 29, 30, 31];
such experiments are often categorised as diffusion-relaxation correlation spectroscopy (DRCOSY) [32]. These acquisi-
tions naturally pairwithmultidimensional analysis techniqueswhich quantifymultiple tissue parameters simultaneously,
and therefore have great potential to yield fine-grained information on tissuemicrostructure. Such analysis techniques
have been recently applied to combined diffusion-relaxometry experiments in the context of nuclear magnetic reso-
nance (NMR) spectroscopy, improving the ability the distinguish different compartments [33, 34]. Recent work applying
these techniques to imaging has applications in the T1-diffusivity [35], T2-diffusivity [36, 37], and T1-T2-diffusivity
[38] domains. These studies have shown that combining diffusion with other MR contrasts leads to more specific
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quantification of microscopic tissue compartments. One recent study demonstrated combined T2-diffusivity in the
placenta [39], with the aim to separate signals from fetal andmaternal circulations.
Amajor disadvantage of previous diffusion-relaxometry experiments are the very long scan times requiredwhen
varying multiple contrast mechanisms, such as the TE and diffusion encoding. In this paper, we propose a combined
acquisition and analysis technique which can estimate the T2*-ADC spectrumwithin a clinically viable timeframe. We
apply this novel method in the placenta, an organ where T2* and ADC have both been shown to be informative. As
well as demonstrating simultaneous estimation of T2* and diffusivity parameters within a clinically viable time, we
hypothesise that the joint T2*-ADC spectrumwill provide additional information compared to the individual measures.
2 | METHODS
2.1 | Acquisition: Integrated T2∗-Diffusion sampling
We adapt a novelMRI acquisition strategy, termed ZEBRA [40], in order to sample multiple TEs and diffusion encodings
within a single repetition time (TR). Themethod combines a diffusion prepared spin echo sequencewith subsequent
gradient echoes. This allows simultaneous quantification of T2* and ADC, as opposed to standard independentmulti-
echo gradient echo and diffusion sequences (e.g. Figure 1a). Our technique also offers significant speed ups compared
to existing T2-diffusivity techniques - which only sample a single TE-diffusion encoding pair for each TR (i.e. Figure 1a).
The proposed combined acquisition is shown in Figure 1b. The multiple gradient echoes are acquired with minimal
spacing after the initial spin echo and diffusion preparation. We note that by using gradient echo readouts rather than
spin echoes, wemeasure T2∗ rather than T2 (see Figure 1c).
Figure 2 illustrates the resultant sampling of the TE-diffusion encoding domain for the three acquisition techniques
presented in Figure 1. Separatemulti-echo gradient echo and diffusion sequences do not adequately sample the full
domain (Figure 2a). With repeat acquisitions of diffusion encodings at different TEs full sampling of the domain is
possible, but very slow (Figure 2b). The proposed acquisition is able to sample the same domain in amuch shorter, and
clinically viable, scanning time (i.e. Figure 2c).
2.2 | Modelling
The simplest model for analysing the data considers single tissue compartments, so that the signal attenuations caused
by T2* relaxation and diffusion are both assumed to give rise to a single exponential decay. The MR signal for this
combined ADC-T2*model is given by
S (TE , b) = S0e−TE /T
∗
2 e−bADC (1)
whereTE is the echo time, b is the b-value, ADC is the apparent diffusion coefficient,T ∗2 is the effective transverse
relaxation time, and S0 is the signal at the spin-echo time with zero diffusion weighting. S0 is the product of proton
density, T2 weighting caused by finite spin echo time, receiver coil properties, and system gain, so we do not treat it as
an absolute quantity in the analysis.
A shortcoming of this model is that it assumes the attenuation due to diffusion is mono-exponential, when it is
well established that the placental dMRI signal in-vivo is at least bi-exponential, as in the intravoxel incoherent motion
(IVIM)model [41]. In this model, the slow and fast attenuating components are associated with diffusion in tissue and
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pseudo-diffusion in capillaries respectively. Incorporating T2* decay into the IVIMmodel gives
S (TE , b) = S0e−TE /T
∗
2
[
f e−bD
∗
+ (1 − f )e−bADC
]
(2)
where f is the perfusion fraction andD ∗ is the pseudo diffusion coefficient. However, it seems likely that the diffusion
and pseudo-diffusion compartments have different T2* values. Amodel incorporating this was proposed by Jerome et
al. [42]
S (TE , b) = S0
[
f e−bD
∗
e
−TE /T ∗2p + (1 − f )e−bADC eTE /T ∗2
]
(3)
whereT ∗2p andT ∗2 are the T2* values specific to the pseudo-diffusion and diffusionmonoexponential signal components
respectively.
A significant limitation of themodels presented in Equations (1) (2) and (3) is that the number of signal components
is assumed to be known. An alternative approach for analysing the signal is a continuummodel, which considers that
spins have a spectrum of relaxivity (or diffusivity) values all contributing to theMRI signal. FollowingMenon et al. [43]
the 1D continuummodels forT ∗2 relaxometry and diffusion are
S (TE ) =
∫
p(T ∗2 )e−TE /T
∗
2 dT ∗2
S (b) = S0
∫
p(ADC )e−bADC dADC .
Here p(T ∗2 ) and p(ADC ) are theT ∗2 relaxation and diffusivity spectra to be estimated from the data. We can solve for
these spectra using an inverse Laplace transformation, although this is an ill-posed problem requiring regularisation
to smooth the resulting spectra [44, 45, 46, 38, 36]. The extension to combined diffusion-relaxometry acquisitions is
simple. For the acquisition presented here, whereTE and b are simultaneously varied, the signal is (e.g. [47] )
S (TE , b) = S0
∫ ∞
0
p(T ∗2 ,ADC )e−T E /T
∗
2 e−bADC dT ∗2 dADC (4)
The function we are interested in is the two-dimensional T2*-diffusivity spectrum, p(T ∗2 ,ADC ), which can be estimated
by a regularised 2D inverse Laplace transform. This contains more information than the individual 1D spectra, and
is hencemore likely to resolvemultiple distinct tissue compartments. Althoughwe emphasise that, due to choice of
kernels in the continuummodels, these distinct compartments - i.e. separate peaks in 2D spectra - are assumed to be
the result of monoexponential signal decays.
2.3 | Experiments
The sequence described in themethods section was implemented on a clinical Philips Achieva-Tx 3T scanner using the
32ch adult cardiac coil placed around the participant’s abdomen for signal reception. All methods were carried out in ac-
cordancewith relevant guidelines and regulations; the studywas approved by the Riverside Research Ethics Committee
(REC 14/LO/1169) and informedwritten consent was obtained prior to imaging. 17 pregnant women, with gestational
age ranging from 23+5 to 35+4 (weeks + days), were successfully scanned using the described technique. Three of these
participants, one of whom also had FGR, were diagnosed with pre-eclampsia according to standard definitions [48].
Three participants had chronic hypertension in pregnancy andwere analysed distinct from normotensive pregnancy
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women (the control group). One pregnant womanwith chronic hypertension was scanned twice, four weeks apart, and
developed superimposed pre-eclampsia by the second scan. The full participant details are given in Table 1.
The combined T2∗-diffusivity scan was acquired with the proposed sequence, a dMRI prepared spin echo followed
bymultiple gradient echos. The number and timing of the gradient echos varied across scans (see Table 1), withmost
scans having five TEs. The diffusion encodings were chosen specifically for the placenta, as previously reported [49, 50],
with 3 diffusion gradient directions at b = [5, 10, 25, 50, 100, 200, 400, 600, 1200, 1600] s mm−2, 8 directions at b =
18 smm−2, 7 at b = 36 smm−2, and 15 at b = 800 smm−2. Further parameters were FOV = 300×320×84mm, TR = 7
s, SENSE = 2.5, halfscan = 0.6, resolution = 3mm3. One participant was scanned at higher resolution: 2mm isotropic.
The total acquisition timewas 8minutes 30 seconds. We acquired all images coronally to themother. Attempting to
acquire images in the same plane relative to the placenta would be very difficult, due to the heterogeneity in placental
positioning and curvature across subjects. In clinical practice the imaging plane with respect to the placenta has to vary
widely; our samples allow us to demonstrate themethod across a range of orientations. Supporting Information Figure
S2 displays raw data from a single acquisition.
2.4 | Model fitting
We first manually defined a region of interest (ROI) containing thewhole placenta and adjacent uterinewall section
on the first b=0 imagewith the lowest TE.We fit the T2*-ADCmodel described in Equation (1) voxelwise to the data
(all TEs and all b-values). The fitting consisted of two-step (grid search followed by gradient descent) maximum log-
likelihood estimation assuming Rician noise, similar to that previously described [17], with the exception that we use the
unnormalisedMRI signal. The gradient descent fitting constraints were as follows: T2* was constrained between 0.001
s and 1 s, the ADC between 10−5 and 1mm2 s−1 , and S0 between 0.001 and 105 . We fixed the SNR for fitting to 20 for all
voxels in all scans.
We calculated the T2*-ADC spectrum for each participant from the signal averaged over the ROIs, using theMERA
toolbox [51], which incorporates minimum amplitude energy regularization as described byWhittall et al. [52]. We
also calculated the T2*-ADC spectra voxelwise in all participants. We next quantified the spatial variation in T2*-ADC
spectral components across the placenta and uterine wall with volume fraction maps, using a similar approach to
Benjamini et al. [38] andKim et al. [36]. Specifically, by inspecting the ROI-averaged spectrawe chose a set of boundaries
- based on themost common peak areas - which split the T2*-ADC domain into regions. These boundaries were the same
across all participants, and are given in Table 2. For each voxel’s T2*-ADC spectrum, we then calculated theweight of
the voxelwise spectra contained in each of these regions. By normalising these weights to sum to 1 across all regions, we
produced spectral volume fraction estimates for each voxel. Figure 3 shows an illustrative example of this calculation;
the spectral volume fraction essentially quantifies the proportion of each voxel’s spectrumwhich lies in each of the
highlighted regions in the top-left panel.
3 | RESULTS
Figure 3 demonstrates the full analysis pipeline output for a single participant. We next present the parametermaps
from combined ADC-T2*model fits (Figures 4 and 5) and spectral volume fractionmaps (Supporting Information Figures
S4, S5 and S6) for all participants. Weprobe the changes across gestation and in disease cases by examining the T2*-ADC
spectra across all participants (Figures 6 and 7). Finally, in order to assess the independence of our diffusivity and
relaxometry measurements, we plot the correlation between the derived ADC and T2* values (Supporting Information
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Figure S7).
The first panel in Figure 3 shows the placenta and uterine wall ROI averaged T2*-ADC spectrum for a single
participant (scanned at higher resolution). We observe three peaks, clearly separated by ADC value but with similar
T2* values. ADC and T2*maps show distinctive spatial patterns. The ADC is much higher in the uterine wall than the
placenta. T2*maps showdistinct ‘lobes’ surrounded by a patchwork of lowT2* values, withmany lobes displaying a small
region of higher T2* in the centre. The bottom row of Figure 3 displays voxelwise spectral volume fractions, obtained by
integrating (i.e summing spectral weights) within three regions of the T2*-ADC space, as described inMethods. The
domain with the lowest ADC (e.g. peak 1) is associatedwith areas within the placenta, and the two domains (peaks 2
and 3) with higher ADC aremore prominent in the uterine wall.
Figure 4 shows T2*maps across all participants from the combined T2*-ADC fit. The patterns are consistent with
those previously reported in the literature [53, 50]. Inmost participants regions of high T2* encircled by lowT2* borders
are clearly visible, andmost likely correspond to placental lobules, with high T2* indicating the presence of oxygenated
blood. In agreement with previous observations the regions with low T2* aremore prominent in pre-eclampsia [50], and
FGR [22, 54] placentas.
ADCmaps (Figure 5) also show anatomically-linked qualitative features which are consistent across participants. In
all scans from the healthy pregnant group the ADC shows a significant increase at the border between the placenta
and the uterine wall. This is most likely explained by the high levels of blood flow in these areas. This bordering area of
high ADC is absent frommany disease placentas. Additionally placentas fromwomenwith chronic hypertension and
pre-eclampsia often show a distinctive pattern - small patches of high ADC surrounded by very lowADC.
Figure 6 displays the spatially averaged T2*-ADC spectra for ROIs containing the placenta and uterine wall. We
clearly observe separate peaks in all control participants, strongly suggesting the presence of multiple tissue compart-
ments with distinct properties. In the vast majority (11/12) of these spectra from healthy controls we see at least three
clearly separated peaks. The ADC values of two of these peaks are typically above the diffusivity of water in freemedia
(Figure 6, blue dashed lines), suggesting multiple microenvironments with different incoherent flow speeds. These
peaks, and their corresponding tissue compartments, appear more clearly separated by ADC (note the log-scale on
the y-axis) than by T2* value. We also observed three distinct peaks in placentas from chronic hypertensive women.
Interestingly, we did not see three distinct peaks in any spectra from participants with pregnancy complications (three
PE, one PE+FGR). There is a distinct pattern in the T2*-ADC spectra for the three PE participants - a left and downward
shift in the lowest peak. This suggests a decrease in both ADC and T2* distributions compared to control placentas.
There is a similar leftward shift in the PE+FGR placental spectrum; however, the downward shift is not as pronounced,
with themiddle peak appearing tomergewith the lowest peak. The peakwith highest ADC often appears to span the
boundary of the domain in which the inverse Laplace transform is calculated. This is likely because we are unable to
sample enough low b-values to accurately estimate this very fast diffusing component - i.e. there is signal in the b = 0
volume, which has all attenuated by the b = 5 s mm−2 volume.
Spectral volume fraction maps showed similar patterns across all control participants (Supporting Information
Figures S4, S5 and S6); peaks with higher ADC beingmore prominent in the uterine wall. This likely reflects the high
flowing blood volumes in these areas, akin to themaps in Figure 5.
Supporting Information Figure S7 shows that we did not observe a consistent correlation between T2* and ADC
values across participants. This suggests that we acquire complementary information from these twoMR contrasts.
Interestingly, we did not observe the small placental areas with high T2* and high ADC that we saw in previous work
[50].
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4 | DISCUSSION AND CONCLUSION
4.1 | Summary
This study demonstrates accelerated diffusion-relaxometryMRI on the in-vivo human placenta. Compared to existing
approaches, it allows denser, faster, andmoreflexible sampling of the 2D (TE - diffusion encoding) acquisition space. This
in turn allows visualization of the T2*-ADC spectrum, and thus provides enhanced capacity to separatemultiple tissue
microenvironments. The technique was demonstrated on 17 pregnant participants, including 3 scans on placentas
clinically assessed as fromwomenwith pregnancy complications. In the following sections, we first putatively associate
the observed T2*-diffusivity spectral peaks with distinct placental tissuemicroenvironments. We then hypothesise as
to how the spectral changes observed in cases with complications reflect changes in these tissuemicroenvironments.
Finally we discuss the clinical potential of the presented technique, which we emphasise is independent of the biological
interpretation.
4.2 | Biological interpretation of T2*-diffusivity spectra
In all controls, we observed a peakwith high ADC, typically above 10−1 mm2 s−1. Additionally, in nearly every control
participant (11/12) we observe two further clearly distinct peaks, with ADC around 2 ×10−3 mm2 s−1 for the lower, and
between 10−2 and 10−1 mm2 s−1 for themiddle peak (Figure 6).
The appearance of three peaks clearly separated by diffusivity in all but one control placenta is consistent with
each peak corresponding to a distinct placental tissuemicrodomain. Solomon et al. previously reported three placental
compartments in mice [55], with these attributed to a slow-diffusing maternal blood compartment, a fetal blood
compartment with diffusivity around two orders of magnitude faster, and an intermediate compartment associated
with active filtration of fluid across the fetal-maternal barrier. We therefore speculatively assign tissue compartments
to each of these three peaks in healthy control placentas as follows. The compartment with the lowest ADC, which
has typical values (2 ×10−3 mm2 s−1) comparable to the diffusivity of water in tissue, is associated with water which
is not subject to significant incoherent flow effects - this may be within tissue or slow-moving maternal blood. The
highest ADC compartment is associated with perfusing fetal blood, and the intermediate compartment with fluid
transitioning between thematernal and fetal circulations - a significant proportion of whichmay reside within tissue.
This is consistentwith the spectral volume fractionmaps for the peakswith higher ADC (Supporting Information Figures
S5 and S6), which show higher intensity in the vascular areas bordering the placenta. The accuracy of these speculative
tissue compartment assignments could be tested by comparison with ex-vivo histology. Although such comparisons are
notoriously challenging, achieving detailed correspondence would be highly valuable.
4.3 | Spectral changes in disease
Weobserved threemain trends in the T2*-diffusivity spectrumwhich discriminated between control and placentas
fromwomenwith pregnancy complications:
1. The disappearance of one (or both) of themiddle and higher peaks
2. The lowest peak has a lower T2*
3. The lowest peak has a lower diffusivity
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In placentas fromwomenwith pre-eclampsia we generally saw all three trends (Figure 6). The lower T2*mirrors
the previously reported decrease in T2* in pre-eclampsia placentas [50]. We saw the same trend in the FGR+PE case,
and note that lower T2* values have also been observed in FGR placentas [56, 22]. Regarding the lower diffusivity in
the lowest peak, our initial speculation is that this could reflect increased water restriction due to inflammation - since
placental inflammation is associatedwith PE [57]. This may relate to the disappearance of themiddle peak, which we
hypothesis could reflect decreasedmaternal-fetal fluid exchange. Inflammation is a potential mechanism facilitating
the reduction in exchange, although we emphasise that this speculative link can only be confirmed (or refuted) by
comparison with post-delivery histology. Figure 7 presents these observed changes in the T2*-ADC spectrum in a single
plot, showing clear separation between the control and pregnancy complication (i.e. PE, PE+FGR) participants. We
plot the position of the spectral peak with the lowest ADC in the T2*-ADC domain, with themarker area corresponding
to the peak’s volume fraction. In this way, we capture both the peak shift, and the higher volume fraction due to the
disappearance of themiddle or higher peaks. Although these results are highly encouraging, we clearly need to scan
manymore participants, both control and womenwith pregnancy complications, to determine the discriminative power
of thesemeasures.
| Limitations and FutureWork
Weused an “out-of-the-box" inverse Laplace transform toolbox to calculate the T2*-ADC spectrum. There are a number
of knownweaknesses for this method, including the need for regularization. In this study we choseminimum amplitude
energy regularization. Future work could assess the utility of alternative optimization approaches, such as spatially
constrained [36], or constrained by the 1D spectra [38].
Our T2* estimates are generally lower than those previously reported [50]. This may be due to the larger voxel size,
leading to partial volume effects around areas with high T2*, such as spiral artery inlets. It could also be due to signal
attenuation due to diffusion during the gradient echoes, something which we did not account for in our analysis.
The presented T2*-ADC spectral analysis assesses the data in two dimensions, but there aremore dimensions to
the data - such as diffusion gradient direction - which we did not include in our analysis. Therefore this dataset has the
potential to be further analysed, for example withmicrostructural models that account for anisotropy in the signal.
In this study, we used b-values and gradient directions optimised for dMRI at a single TE [58, 50], and the TEs
were constrained by the EPI read-out train length. Separate optimisation of T2∗ relaxometry and dMRI acquisition
parameters is 1D (choice of TEs, choice of b-values). However, whenmoving to combined T2∗-diffusion this becomes a
2D problem - for example, in the isotropic case we need to choose optimal TE-diffusion encoding pairs. In future, we
plan to optimise these TE-diffusion encoding values in order to give the best sampling of the 2D parameter space, and
enhance estimation of the 2D spectra.
4.4 | Outlook and clinical application
The combined acquisition and analysis technique presented here offers fast, simultaneous, and multidimensional
assessment of placental T2* and diffusivity in less than 10minutes. These twoMR contrasts have been shown elsewhere
to be sensitive to placental pathologies, we hypothesise that their simultaneous assessment could enable better
separation of healthy and poorly functioning placentas. This is supported by the fact that we did not see consistent
correlation between T2* and ADC values (Supporting Information Figure S7), suggesting that thesemodalities offer
complementary information. This reinforces the value of the novel technique presented here as a quantitative tool
for assessment of pregnancy complications, with the potential to ultimately inform clinical decisions. Furthermore,
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we believe that fast calculation of the T2*-ADC spectrum hasmany potential applications in other areas of biomedical
research.
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F IGURE 1 The considered acquisition schemes. (a) Conventional DiffusionMRI acquisition for one echo time (TE)
showing the diffusion gradients (blue), the excitation and refocusing pulses as well as the single-shot EPI read-out train.
Repeating this acquisition with varying delays between the diffusion gradients and the read-out leads to different TEs
and thus combined T2-DiffusionMRI. (b) Proposed combined acquisition with an initial spin-echo acquired after the
diffusion gradients followed bymultiple Gradient echos. (c) Magnetization for the combined acquisition, with both T2
and T2* decay. The signal evolution neglects effects of all applied gradients.
F IGURE 2 Schemes for the three considered diffusion-relaxometry experiments illustrated in the TE-Diffusion
encoding acquisition parameter plane. (a) Schematic of conventional separate T2* mapping and DiffusionMRI showing
the encoding of different echo times for b=0 in blue and different diffusion encoding settings at fixed echo time. (b)
Parameter space illustrating the sampling of the TE-diffusivity space with diffusion acquisitions at several TEs. Shading
illustrates separate diffusion acquisitions at fixed TEs. (c) Proposed combined T2∗-diffusion acquisition illustrating a
denser sampling scheme achieved in a single acquisition.
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TABLE 1 Participant details. PE - pre-eclampsia, CH - chronic hypertensive, FGR - fetal growth restriction.
Participant ID GA at scan (weeks) Cohort TEs (ms)
1 23.72 Control 78, 114, 150, 186, 222
2 23.86 Control 78, 114, 150, 186, 222
3 25.43 Control 78, 114, 150, 186, 222
4 25.72 Control 78, 114, 150, 186, 222
5 26.14 Control 78, 114, 150, 186, 222
6 26.72 Control 78, 114, 150, 186
7 26.72 Control 78, 114, 150, 186, 222
8 27.14 Control 78, 114, 150, 186, 222
9 28.29 Control 78, 114, 150, 186, 222
10 28.86 Control 82, 175, 268, 361, 454
11 28.86 Control 78, 114, 150, 186, 222
12 29.67 Control 85, 145, 205, 265, 325
13 26.86 CH 80, 121, 162, 203, 245
14 34.43 CH 78, 114, 150, 186, 222
15 27.7 PE+FGR 78, 114, 150, 186, 222
16 30.58 PE 78, 114, 150
17 (scan 1) 30.71 CH 78, 114, 150, 186, 222
17 (scan 2) 34.14 CH+PE 78, 114, 150, 186, 222
TABLE 2 Boundaries selected to segregatemost common peak areas in T2*-ADC spectra.
Region ADCBounds (×10−3 mm2 s−1) T2* Bounds (s)
Peak 1 0 < ADC < 25 0 < T2* < 0.1
Peak 2 25 < ADC < 200 0 < T2* < 0.1
Peak 3 200 < ADC < 1000 0 < T2* < 0.1
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F IGURE 3 T2*-ADC spectra show anatomical specificity. Spatial maps for a single scan with higher resolution. Top
row: T2*-ADC spectrum derived from inverse Laplace transforms of the spatially averaged signal within an ROI
comprising the entire placenta and uterine wall, and ADC and T2*maps from combined T2*-ADC fit. The
manually-defined placenta ROI is outlined in the T2*map. Bottom row, spectral volume fractionmaps derived by
summing the weight of the spectra in the 3 domains displayed in the ROI averaged spectrum, as described inMethods.
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F IGURE 4 T2*maps from combined ADC-T2* fit. Participants with pregnancy complications in colour. The
manually-defined placenta ROI is outlined. Note the very high T2* values for the GA = 30.58 participant - this is very
likely due tomodel fitting failure caused by very low signal in this placenta.
F IGURE 5 ADCmaps from combined ADC-T2* fit. Themanually-defined placenta ROI is outlined. Note the
log-scale colormap.
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F IGURE 6 T2*-ADC spectra derived from inverse Laplace transforms of the spatially averaged signal within
placenta and uterine wall ROIs. Horizontal dashed blue lines represent the approximate diffusivity of water in free
media at 37◦C (3 ×10−3 mm2 s−1).
F IGURE 7 Position of the peak with the lowest ADCwithin the ADC-T2* spectrum. Eachmarker corresponds to a
single scan. Markers are colored by disease cohort, andmarker area is proportional to the spectral volume fraction of
the peak.
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SUPPORT ING INFORMATION TABLE S1 Overview of placental T2∗ and dMRI studies to date.
Reference Parameters Resolution ROI selection
T2∗
Sinding2016[56] 1.5T, gradient-recalled echo) 1.37x2.73x8mm Entire placenta,
16 TEs(3-67.5) (2 slices, gap 2mm) outer border not crossed
BH 12s, 16 controls with repetitions
Sinding2017[19] 1.5T, gradient-recalled echo) 1.37x2.73x8mm Entire placenta,
16 TEs(3-67.5) 3 slices outer border not crossed
BH 12s transverse evenly
Sinding2018[22] 1.5T, gradient-recalled echo) 1.37x2.73x8mm entire placenta
16 TEs(3-67.5) 3 planes evenly adjusted for movements
BH 12s, 16 HCwith repetitions
Derwig2013a[21] 1.5T, flow-compensated SE (ind. scans) 3.76x3.75x8 representative area of central part
TEs= 40,80,120,180,240,300,360,440 3 slices, no gap away from vessels
Ingram2017 [20] gradient-recalled echo 3.52x3.52 largest contiguous placental region
5-50ms, 8 sec BH, under O2 1 slices transverse non-placental tissue removed
Hutter2018[50] 2D ss EPIMulti-echo GE 2x2x2 conservative
dMRI
Moore2000a[59] 0.5T, 11 b-values (0-468 smm−2) 3.5×2.5×7mm Entire placenta
Moore2000b[14] 0.5T,11 b-values (0-468 smm−2) 3.5×2.5×7mm Entire placenta
Derwig2013b[15] 1.5T, 11 b-values (0-500 smm−2) 3.75×3.75×4mm Two: central, whole
Sohlberg2015[25] 1.5T, 5 b-values (0-800 smm−2) ??×??×6mm excluding artefactual signal loss areas
You2017[60] 1.5T, 9 b-values (0-900 smm−2) 4.38×4.38×4mm Entire placenta
Capuani2017[61] 1.5T, 7 b-values (0-1000 smm−2) 2×2×4mm Three: central, peripheral, umbilical
Siauve2017[62] 1.5T, 11 b-values (0-1000 smm−2) ??×??×5mm Three: entire placenta, fetal, maternal
Slator2017[17] 3T, 12 b-values (0-2000 smm−2) 2×2×2mm Entire placenta
Jakab2017[63] 1.5T and 3T, 17 b-values (0-900 smm−2) 2×2×4mm Central
Hutter2018[50] 3T, 14 b-values (0-1600 smm−2) 2×2×2mm Entire placenta
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SUPPORT ING INFORMATION F IGURE S2 Exemplary raw volumes from placental
diffusivity-relaxometry scan. The resolution was 2mm isotropic - see Experiments section inMethods for further
acquisition parameters. We display 70 out of the full set of 330 contrast encodings. Note that each row has a different
color scaling. Figure 3 shows the derived T2*-ADC spectrum andmaps for this scan.
SUPPORT ING INFORMATION F IGURE S3 T2*-ADC spectra derived from inverse Laplace transforms of
the spatially averaged signal within placenta ROIs. Horizontal dashed blue lines represent the approximate diffusivity
of water in freemedia at 37◦C (3 ×10−3 mm2 s−1).
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SUPPORT ING INFORMATION F IGURE S4 Spectral volume fractionmaps, obtained by summing the
T2*-ADC spectrumweight within the domain where ADC < 25 × 10−3 mm2 s−1.
SUPPORT ING INFORMATION F IGURE S5 As Figure S3, but for the domain where 25 × 10−3 mm2
s−1 < ADC < 200 × 10−3 mm2 s−1.
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SUPPORT ING INFORMATION F IGURE S6 As Figure S3, but for the domain where 200 × 10−3 mm2
s−1 < ADC < 1000 × 10−3 mm2 s−1.
SUPPORT ING INFORMATION F IGURE S7 Correlation between T2* and ADC from combined ADC-T2*
fit within placental ROIs. Horizontal blue dashed lines represents the approximate diffusivity of water in freemedia at
37◦C (3 ×10−3 mm2 s−1).
